Hans Schreiber

19.1k total citations · 1 hit paper
252 papers, 13.1k citations indexed

About

Hans Schreiber is a scholar working on Immunology, Oncology and Surgery. According to data from OpenAlex, Hans Schreiber has authored 252 papers receiving a total of 13.1k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Immunology, 95 papers in Oncology and 51 papers in Surgery. Recurrent topics in Hans Schreiber's work include Immunotherapy and Immune Responses (97 papers), CAR-T cell therapy research (54 papers) and Monoclonal and Polyclonal Antibodies Research (39 papers). Hans Schreiber is often cited by papers focused on Immunotherapy and Immune Responses (97 papers), CAR-T cell therapy research (54 papers) and Monoclonal and Polyclonal Antibodies Research (39 papers). Hans Schreiber collaborates with scholars based in United States, Germany and Japan. Hans Schreiber's co-authors include Yang‐Xin Fu, Thomas F. Gajewski, Donald A. Rowley, Mary Philip, J L Urban, Jay L. Rothstein, Michael T. Spiotto, Andrea Schietinger, Ping Yu and Stephen C. Meredith and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Hans Schreiber

238 papers receiving 12.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Innate and adaptive immune cells in the tumor microenvironment

2013 3.1k citations Hans Schreiber, Yang‐Xin Fu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hans Schreiber United States	54	7.9k	6.7k	3.6k	1.4k	1.3k	252	13.1k
Hiroshi Shiku Japan	64	6.6k 0.8×	4.4k 0.7×	6.7k 1.9×	1.3k 0.9×	1.2k 0.9×	535	16.3k
Keith L. Knutson United States	55	6.7k 0.9×	6.4k 1.0×	4.7k 1.3×	1.7k 1.2×	1.4k 1.2×	187	14.3k
Barbara Seliger Germany	65	8.1k 1.0×	6.3k 0.9×	5.3k 1.5×	1.8k 1.2×	1.4k 1.1×	362	15.2k
Koji Tamada Japan	54	11.8k 1.5×	10.6k 1.6×	2.8k 0.8×	863 0.6×	1.4k 1.1×	147	17.4k
D Metcalf Australia	77	9.3k 1.2×	5.4k 0.8×	6.3k 1.8×	825 0.6×	1.3k 1.1×	274	21.1k
James J. Mulé United States	60	9.1k 1.1×	6.1k 0.9×	3.6k 1.0×	813 0.6×	668 0.5×	167	12.8k
Gert Riethmüller Germany	47	3.3k 0.4×	5.1k 0.8×	3.1k 0.9×	2.2k 1.6×	1.1k 0.8×	112	10.4k
Jonathan Cebon Australia	62	6.6k 0.8×	6.3k 0.9×	4.7k 1.3×	943 0.7×	1.2k 1.0×	278	13.6k
Ena Wang United States	67	7.2k 0.9×	6.3k 0.9×	5.4k 1.5×	2.0k 1.4×	949 0.8×	260	14.2k
John G. Gribben United Kingdom	89	10.9k 1.4×	8.4k 1.3×	5.0k 1.4×	1.3k 1.0×	1.3k 1.0×	481	24.1k

Countries citing papers authored by Hans Schreiber

Since Specialization

Citations

This map shows the geographic impact of Hans Schreiber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Schreiber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Schreiber more than expected).

Fields of papers citing papers by Hans Schreiber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Schreiber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Schreiber. The network helps show where Hans Schreiber may publish in the future.

Co-authorship network of co-authors of Hans Schreiber

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Schreiber. A scholar is included among the top collaborators of Hans Schreiber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Schreiber. Hans Schreiber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hansmann, Leo, Guoshuai Cao, Jun Huang, et al.. (2025). Selection of therapeutically effective T-cell receptors from the diverse tumor-bearing repertoire. Journal for ImmunoTherapy of Cancer. 13(5). e011351–e011351. 2 indexed citations

Vickman, Renee E., Yuefeng Yang, Zebin Hu, et al.. (2024). The safety and efficacy of systemic delivery of a new liver-de-targeted TGFβ signaling inhibiting adenovirus in an immunocompetent triple negative mouse mammary tumor model. Cancer Gene Therapy. 31(4). 574–585. 2 indexed citations

Leisegang, Matthias, V.C.J. Wallace, Kazuma Kiyotani, et al.. (2024). CD4 ⁺ T cells with convergent TCR recombination reprogram stroma and halt tumor progression in adoptive therapy. Science Immunology. 9(99). eadp6529–eadp6529. 3 indexed citations

Engels, Boris, Poh Yin Yew, Kazuma Kiyotani, et al.. (2024). One CD4+TCR and One CD8+TCR Targeting Autochthonous Neoantigens Are Essential and Sufficient for Tumor Eradication. Clinical Cancer Research. 30(8). 1642–1654. 11 indexed citations

Rañoa, Diana Rose E., Preeti Sharma, Marlies V. Hager, et al.. (2023). Single CAR-T cell treatment controls disseminated ovarian cancer in a syngeneic mouse model. Journal for ImmunoTherapy of Cancer. 11(5). e006509–e006509. 10 indexed citations

Friedman, Jay, Ellen Moore, Paul Zolkind, et al.. (2019). Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen–Specific T Cells. Clinical Cancer Research. 26(3). 679–689. 57 indexed citations

Schreiber, Karin, Theodore Karrison, Kazuma Kiyotani, et al.. (2019). Impact of TCR Diversity on the Development of Transplanted or Chemically Induced Tumors. Cancer Immunology Research. 8(2). 192–202. 18 indexed citations

Sasmal, Dibyendu K., Wei Feng, Sobhan Roy, et al.. (2019). TCR–pMHC bond conformation controls TCR ligand discrimination. Cellular and Molecular Immunology. 17(3). 203–217. 28 indexed citations

Arina, Ainhoa, et al.. (2017). Transfer of Allogeneic CD4+ T Cells Rescues CD8+ T Cells in Anti-PD-L1–Resistant Tumors Leading to Tumor Eradication. Cancer Immunology Research. 5(2). 127–136. 14 indexed citations

10.

Leisegang, Matthias, Boris Engels, Karin Schreiber, et al.. (2015). Eradication of Large Solid Tumors by Gene Therapy with a T-Cell Receptor Targeting a Single Cancer-Specific Point Mutation. Clinical Cancer Research. 22(11). 2734–2743. 59 indexed citations

11.

Binder, David C., Boris Engels, Ainhoa Arina, et al.. (2013). Antigen-Specific Bacterial Vaccine Combined with Anti-PD-L1 Rescues Dysfunctional Endogenous T Cells to Reject Long-Established Cancer. Cancer Immunology Research. 1(2). 123–133. 65 indexed citations

12.

Liu, Rebecca B., Boris Engels, Ainhoa Arina, et al.. (2012). Densely Granulated Murine NK Cells Eradicate Large Solid Tumors. Cancer Research. 72(8). 1964–1974. 45 indexed citations

13.

Schreiber, Karin, Ainhoa Arina, Boris Engels, et al.. (2012). Spleen Cells from Young but Not Old Immunized Mice Eradicate Large Established Cancers. Clinical Cancer Research. 18(9). 2526–2533. 21 indexed citations

14.

Zhang, Bin, Yi Zhang, Natalie A. Bowerman, et al.. (2008). Equilibrium between Host and Cancer Caused by Effector T Cells Killing Tumor Stroma. Cancer Research. 68(5). 1563–1571. 59 indexed citations

15.

Schietinger, Andrea, Mary Philip, Barbara A. Yoshida, et al.. (2006). A Mutant Chaperone Converts a Wild-Type Protein into a Tumor-Specific Antigen. Science. 314(5797). 304–308. 125 indexed citations

16.

Schumpelick, V., et al.. (1983). Ulcusrisiko durch Refluxverhtung?: Ergebnisse der Jejunum-Interposition. Langenbecks Archiv für Chirurgie. 360(3). 179–191. 1 indexed citations

17.

Jung, Heike & Hans Schreiber. (1981). Arzt und Patient zwischen Therapie und Recht. 2 indexed citations

18.

Schreiber, Hans, et al.. (1977). [Pancreas resection, -extirpation, reparation through isoperistaltic segment-interposition].. PubMed. 48(9). 607–12. 1 indexed citations

19.

Winkler, R, et al.. (1977). Das Carcinom am Anus praeter* Tierexperimentelle Untersuchungen und klinische Beobachtungen. Langenbecks Archiv für Chirurgie. 343(3). 229–241. 2 indexed citations

20.

Schreiber, Hans, et al.. (1960). Die Chirurgie des Magensarkoms. Thieme eBooks. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact